𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prospective study of cytomegalovirus serostatus and prostate cancer risk in the Prostate Cancer Prevention Trial

✍ Scribed by Siobhan Sutcliffe, Cathee Till, Charlotte A. Gaydos, Frank J. Jenkins, Phyllis J. Goodman, Ashraful M. Hoque, Ann W. Hsing, Ian M. Thompson, Jonathan M. Zenilman, William G. Nelson, Angelo M. De Marzo, Elizabeth A. Platz

Book ID
118797052
Publisher
Springer Netherlands
Year
2012
Tongue
English
Weight
186 KB
Volume
23
Category
Article
ISSN
0957-5243

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Trichomonosis and subsequent risk of pro
Trichomonosis and subsequent risk of prostate cancer in the Prostate Cancer Prevention Trial
✍ Siobhan Sutcliffe; John F. Alderete; Cathee Till; Phyllis J. Goodman; Ann W. Hsi πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 94 KB πŸ‘ 1 views

## Abstract We previously observed a positive association between a history of trichomonosis, a sexually transmitted infection caused by the protozoan, __Trichomonas vaginalis__, and prostate cancer risk in the Health Professionals Follow‐up Study. To determine the reproducibility of this finding,

Chemoprevention of prostate cancer: The
Chemoprevention of prostate cancer: The prostate cancer prevention trial
✍ Thompson, Ian M.; Coltman, Charles A.; Crowley, John πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 67 KB πŸ‘ 2 views

## BACKGROUND. A variety of innovative approaches to the prevention of prostate cancer are now available, including selenium, alpha tocopherol, dietary interventions, and vitamin D. Perhaps the most promising opportunity is based upon considerable evidence that cumulative androgen exposure of the

Serum estrogen levels and prostate cance
Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case–control study
✍ Song Yao; Cathee Till; Alan R. Kristal; Phyllis J. Goodman; Ann W. Hsing; Cather πŸ“‚ Article πŸ“… 2011 πŸ› Springer Netherlands 🌐 English βš– 190 KB

## Objective Finasteride reduces prostate cancer risk by blocking the conversion of testosterone to dihydrotestosterone. However, whether finasteride affects estrogens levels or change in estrogens affects prostate cancer risk is unknown. ## Methods These questions were investigated in a case–con